The United States Food and Drug Administration is recalling the blood pressure medication losartan after finding contamination that could cause cancer. The FDA and Sandoz announced on Friday that the Novartis unit is recalling one lot of losartan that was manufactured by its Lek Pharmaceuticals unit in Ljubljana, Slovenia, because its contains N-nitrosodiethylamine (NDEA), a suspected […]
